Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2849039 | American Heart Journal | 2008 | 8 Pages |
Abstract
In patients with moderate hypercholesterolemia, both low- and high-dose rosuvastatin were effective in reducing low-density lipoprotein cholesterol. Furthermore, rosuvastatin was associated with a reduction in %LRNC, whereas the overall plaque burden remained unchanged over the course of 2 years of treatment. These findings provide evidence that statin therapy may have a beneficial effect on plaque volume and composition, as assessed by noninvasive MRI.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hunter R. MD, Chun PhD, Xue-Qiao MD, Larry W. MD, Dennis L. PhD, Tobias MD, Baocheng MD, PhD, Norihide MD, PhD, Fei PhD, Nayak L. PhD, Blazej MS, Joel S. MD, Valerie A. MS, John C. PhD, Wendy BS, CCRC, Thomas S. MD,